Key Takeaways
- • Private equity healthcare investment reached a record $191 billion in global deal value during 2025, surpassing the previous 2021 peak, with 445 buyouts executed—the second-highest annual total on record, according to Bain & Company.
- • Exit values rebounded sharply to $156 billion in 2025 from just $54 billion in 2024, signaling improved monetization conditions and investor confidence in portfolio performance.
- • Healthcare IT and AI investments accelerated dramatically, with PE-backed healthcare IT reaching $14.6 billion in 2025—a 595 percent increase from $2 billion in 2024—while overall healthcare IT deal value doubled to approximately $32 billion.
- • Digital health companies raised $7.4 billion in the first half of 2026 alone (up from $6.4 billion in H1 2025), demonstrating sustained momentum in technology-driven healthcare solutions beyond traditional buyout activity.
- • Three strategic investment sectors dominate PE allocations: healthcare technology and AI, physician practices, and post-acute care, with AI increasingly functioning as a critical diligence criterion for evaluating portfolio target readiness and operational scalability.
Summary
Private equity firms deployed record capital into global healthcare markets during 2025, channeling $191 billion in aggregate deal value across 445 transactions. This milestone surpasses the previous all-time high established in 2021, reflecting renewed confidence among institutional capital allocators in healthcare acquisition economics. The 2025 activity followed a marked compression in 2024, when exit values collapsed to $54 billion before recovering to $156 billion in 2025—a 189 percent year-over-year rebound that underscores improving conditions for portfolio realizations and secondary market activity.
The composition of 2025 deal flow reveals a pronounced strategic pivot toward innovation and operational transformation. Healthcare information technology commanded particular attention, with PE-backed healthcare IT investments surging to $14.6 billion—a 595 percent increase from $2 billion in 2024. Across all healthcare IT transactions, deal value approximately doubled to $32 billion, according to PitchBook data. This surge reflects broader recognition among PE sponsors that technology infrastructure now functions as a core value driver rather than an ancillary business function. Digital health capital raising accelerated further into 2026, with $7.4 billion deployed in the first half of the year compared to $6.4 billion in the same period of 2025, indicating sustained investor appetite despite elevated interest rate environments affecting other sectors.
Artificial intelligence has emerged as the dominant investment thesis within healthcare PE strategy. PE firms increasingly evaluate acquisition targets through the lens of AI readiness and operational scalability, with generative AI applications spanning revenue cycle management, claims processing, and payment optimization. Clinical applications of AI present even more significant value opportunities alongside complex regulatory challenges that will require resolution as deployment accelerates. Three investment buckets structure PE activity: healthcare technology and AI platforms, physician practice consolidation, and post-acute care infrastructure. With public capital markets under sustained pressure, private equity capital has become a primary funding source for healthcare innovation and consolidation initiatives across these segments.
The composition of 2025 deal flow reveals a pronounced strategic pivot toward innovation and operational transformation. Healthcare information technology commanded particular attention, with PE-backed healthcare IT investments surging to $14.6 billion—a 595 percent increase from $2 billion in 2024. Across all healthcare IT transactions, deal value approximately doubled to $32 billion, according to PitchBook data. This surge reflects broader recognition among PE sponsors that technology infrastructure now functions as a core value driver rather than an ancillary business function. Digital health capital raising accelerated further into 2026, with $7.4 billion deployed in the first half of the year compared to $6.4 billion in the same period of 2025, indicating sustained investor appetite despite elevated interest rate environments affecting other sectors.
Artificial intelligence has emerged as the dominant investment thesis within healthcare PE strategy. PE firms increasingly evaluate acquisition targets through the lens of AI readiness and operational scalability, with generative AI applications spanning revenue cycle management, claims processing, and payment optimization. Clinical applications of AI present even more significant value opportunities alongside complex regulatory challenges that will require resolution as deployment accelerates. Three investment buckets structure PE activity: healthcare technology and AI platforms, physician practice consolidation, and post-acute care infrastructure. With public capital markets under sustained pressure, private equity capital has become a primary funding source for healthcare innovation and consolidation initiatives across these segments.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.